Early CAR-T patient labeled as 'cured'; Biden's new 'Cancer Moonshot' is far more modest

Researchers reported that the first two patients treated with CAR-T therapy remained cancer-free for a decade. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Researchers label early CAR-T therapy patient 'cured' after living a decade without cancer By Angus Chen Wellcome Collection Researchers reported this week that the first two patients treated with CAR-T therapy remained cancer-free for a decade. Read More Biden once pledged to 'cure cancer.' His new approach is far more modest By Lev Facher Win McNamee/Getty Images Biden has been pledging to "cure" cancer for the past six years, beginning with his moonshot. His new effort is far more modest. Read More Could Pap smears one day help detect breast and ovarian cancers? By Angus Chen Suzi Pratt/Getty Images for Hologic New research suggests routine Pap smears to screen for cervical cancer could one day be used to predict breast and ovarian cancer risk. Read More Sponsor content by STAT Events The STAT Breakthrough Science Summit At this March 31 event, executives, researchers, scientists, and investors will take the stage to discuss the technologies and procedures at the cutting edge of health and medicine. Get your ticket now to learn about the latest efforts to battle diseases and help patients. STAT+: FDA's top cancer regulator gives cool reception to drug Lilly licensed from Chinese drugmaker By Adam Feuerstein Kristoffer Tripplaar/AP Writing in Lancet Oncology, the FDA’s Richard Pazdur described imported cancer drug data from China as a “bridge over troubled waters.” Read More STAT+: With cancer biomarkers, experts say the future has finally arrived By Damian Garde STAT Researchers believe they finally have the tools and techniques to live up to lofty promises made decades ago about potential treatments. Read More Opinion: Cancer moonshot 2.0: A missed opportunity for prevention By Nicholas Freudenberg AP Photo/Jose Luis Magana To "end cancer as we know it" will require strategic investments in prevention and screening, which are notably absent from Moonshot 2.0. Read More STAT+: A San Diego biotech's massive valuation turned heads. Now, mass layoffs raise questions By Jonathan Wosen and Matthew Herper Jonathan Wosen/STAT The layoffs could be seen as yet another reality check for the outsized bets made by some investors on privately held biotechnology firms. Read More STAT+: Key lawmaker: ARPA-H won't be part of NIH By Lev Facher Chip Somodevilla/Getty Images Rep. Anna Eshoo told STAT that ARPA-H, the moonshot agency meant to “end cancer as we know it,” won’t be housed within the NIH. Read More Tuesday, February 8, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser